YVONNE QUINN: Good morning. We’ll get started on the second
part of merger discussions this morning. I’m Yvonne Quinn. I’m a partner
at Sullivan & Cromwell here in New York. I’m very pleased to be here
today to talk about some interesting topics relating to merger control.
You can tell that they are interesting. I think it was the very last
comment of Commissioner Almunia on his views on what’s structural,
what’s behavioral, and his preference for structure, which is something
that all of us are familiar with in this area. My definitions of what is
behavioral versus structural might be a little different. I think the panel
here may have some different views on that.
So this is a very timely topic. We’re going to deal with behavioral
remedies. We’re also going to deal with partial acquisitions.
Let me introduce the panel so that we can just flow from there. To
my immediate left is Simon Baxter, who is the co-head of Skadden Arps —
or I should just say Skadden; I’m dating myself there — its European
antitrust and competition practice. He focuses a great deal on merger
activities. He is regularly speaking on these topics. I have had the great
pleasure of working with Simon on merger work in the past.
To his left is Enrique González-Díaz, who is a partner in the Brussels
office of Cleary Gottlieb. He focuses on European practice and many
antitrust areas, but in particular on mergers. We have the great pleasure of
having him here on several levels, including the fact that he has spent time
Yvonne Quinn, Sullivan & Cromwell LLP, New York
Simon Baxter, Skadden, Arps, Slate, Meagher & Flom LLP, Brussels
Francisco Enrique Gonzalez-Diaz, Cleary Gottlieb Steen & Hamilton LLP, Brussels
Ken Heyer, U.S. Department of Justice, Washington
Daniel P. O’Brien, U.S. Federal Trade Commission, Washington